Conference abstract · 6 Oct 2015
Conference abstractPublished 3 Jun 2019
The human viral challenge model-accelerating vaccine development
VIVO, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Since the beginning of the millennium, Human Viral Challenge Studies have successfully been conducted at hVIVO to develop a series of well-characterised virus stocks, whilst demonstrating that the Human Viral Challenge Model (HVCM) could be effective in offering a faster and cost-effective route to market for their therapeutics. The Human Viral Challenge Model enables global pharmaceutical and biotechnology companies, as well as leading academic groups and government institutions, to undertake scientific research, accelerate the drug development timeline and reduce the cost of bringing vaccines, antiviral drugs and diagnostics to market. The HVCM also enables fundamental research into the human response to infection and crucial research into modes of infection and transmission between individuals in the community. The HVCM has become widely accepted as an alternative to traditional early stage field trials to show the efficacy of vaccine and antiviral therapeutics in Influenza, Respiratory Syncytial Virus (RSV) and Human Rhinovirus (HRV). By monitoring the entire disease lifecycle as subjects move from healthy to sick and recover back to healthy again, we can obtain high quality, longitudinal data from the before, during and after phases of disease. The model can be used to study the efficacy of new therapies and also to study the target disease itself. Such studies provide key outcomes about promising investigational medicinal products, their mechanism of action, and their most appropriate dose and dosage regimen, which can then be applied to design further Phase IIb and Phase III studies. Recent Publications 1. Wilkinson, Tom M (2012) Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in human. Nature Medicine 18:274–280. 2. DeVincenzo, John P. (2014) Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study. N Engl J Med 371:711-722. 3. DeVincenzo, John P. (2015) Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study. N Engl J Med 373:2048-2058. 4. Lambkin-Williams, Rob (2016) An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection. Pone 11(12):e016308. 5. Lambkin-Williams, Rob (2018) The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics. Respir Res. 1:123.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 31 Oct 2016
The human viral challenge model: Accelerating drug and vaccine development
Conference abstract · 24 Aug 2015
‘The Human Viral Challenge Model – Accelerating Antiviral and Vaccine Development’
Conference abstract · 8 Jun 2015
Accelerating influenza research; Vaccines, antivirals, immunodulators and monoclonal antibodies: The manufacture of a new H3N2 virus for the human viral challenge model
Conference abstract · 9 Dec 2025
Viral haemorrhagic fevers in Africa: challenges and advances in vaccine development
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Perspective · 10 Sep 2026
Cellular Pathways Involved in Mucosal Immunity and Protection Against Environmental Challenges
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Anthony S Gilbert”

